Sorcin, a potential therapeutic target for reversing multidrug  resistance in cancer.
Department of Pharmacology, School of Pharmaceutical Sciences, Shandong University, Jinan 250012, People’s Republic of China.
Bei-Bei
BB
Zheng
Peng
P
Zhang
Wei-Wei
WW
Jia
Lu-Gang
LG
Yu
Xiu-Li
XL
Guo
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1 / Q000378:metabolism; D000818:Animals; D017209:Apoptosis; D002135:Calcium-Binding Proteins / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*; D018432:Drug Resistance, Multiple; D019008:Drug Resistance, Neoplasm; D055785:Gene Knockdown Techniques; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D017434:Protein Structure, Tertiary; D034622:RNA Interference
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D002135:Calcium-Binding Proteins; C503113:SRI protein, human